Bank of America’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,508
Closed -$182K 6684
2025
Q4
$182K Hold
3,508
﹤0.01% 5385
2025
Q3
$149K Hold
3,508
﹤0.01% 6414
2025
Q2
$143K Hold
3,508
﹤0.01% 6340
2025
Q1
$170K Hold
3,508
﹤0.01% 6261
2024
Q4
$154K Hold
3,508
﹤0.01% 6226
2024
Q3
$196K Buy
+3,508
New +$191K ﹤0.01% 6003
2019
Q2
Sell
-400
Closed -$10K 7376
2019
Q1
$10K Buy
+400
New +$10.1K ﹤0.01% 6659
2016
Q3
Sell
-3,200
Closed -$51K 7320
2016
Q2
$51K Buy
+3,200
New +$49.4K ﹤0.01% 5829
2013
Q4
Sell
-4,000
Closed -$34K 8095
2013
Q3
$34K Sell
4,000
-6,320
-61% -$53.3K ﹤0.01% 6642
2013
Q2
$78K Buy
+10,320
New +$78.4K ﹤0.01% 6304

Other funds holding RXL

Bank of America's RXL Position: Q1 2026 in Review

Bank of America sold out of ProShares Ultra Health Care (RXL) in Q1 2026, closing a stake of 3,508 shares — an estimated $182K sold.

Bank of America first reported a position in RXL in Q2 2013 and held it in 10 quarters. The position peaked at $196K in Q3 2024. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2026.

  • Bank of America reported no remaining ProShares Ultra Health Care position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3,508 ProShares Ultra Health Care shares in Q1 2026, an estimated $182K.
  • Bank of America first reported a position in ProShares Ultra Health Care in Q2 2013 and held it in 10 quarters.
  • Bank of America's ProShares Ultra Health Care position peaked at $196K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.